Status:
COMPLETED
Effect of Revival Soy on Fibromyalgia Pain
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
Physicians Pharmaceuticals, Inc.
Conditions:
Fibromyalgia
Eligibility:
All Genders
18-76 years
Phase:
NA
Brief Summary
Fibromyalgia is characterized by widespread pain that can lead to significant patient dysfunction and economic burden to society. The management of patients with fibromyalgia is difficult and no singl...
Detailed Description
Fibromyalgia syndrome is a chronic, generalized pain syndrome that affects the musculoskeletal system (1). This syndrome is typically diagnosed in patients who experience generalized musculoskeletal p...
Eligibility Criteria
Inclusion
- Women and men age 18 - 76
- Able to understand and sign a consent form
- Able to participate fully in all aspects of the study
- Currently participating in Mayo Clinic's Fibromyalgia Treatment Program
Exclusion
- Pregnant or lactating women
- Allergy to soy or other study product ingredients
- Diagnosis of bipolar disorder, schizophrenia or dementia
- Diagnosis of diabetes mellitus or inflammatory bowel disease
- Presently on soy product or use of soy within the last 30 days
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2006
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00279942
Start Date
May 1 2006
End Date
September 1 2006
Last Update
January 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905